Tvardi Therapeutics

TVRDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$20.942 M

$1.57 -2.48%

Close of 22 Sept 2026

Revenue

$7.14M

#3221 by revenue

Earnings

-$18.2M

Loss-making

Shares outstanding

13,338,943

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#393Atossa TherapeuticsATOS$22.6M
#394Cellectar BiosciencesCLRB$21.1M
#395Tvardi TherapeuticsTVRD$20.9M
#396Marker TherapeuticsMRKR$20.3M
#397Neuphoria TherapeuticsNEUP$20.2M

What if Tvardi Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,266,594

Per share 1,443,690× higher

Bitcoin $1.74T

$130,569.19

Per share 83,165× higher

Nvidia $5.52T

$413,508.54

Per share 263,381× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Tvardi Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.